Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-03-05 @ 12:37 AM
Study NCT ID:
NCT05698303
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-01-26
First Post:
2022-12-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
Sponsor:
Nanjing IASO Biotechnology Co., Ltd.
Organization: